Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, 263-8555, Japan.
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, 9713, GZ, The Netherlands.
Med Phys. 2018 Nov;45(11):e994-e1010. doi: 10.1002/mp.12679.
In this review article, we introduced the importance of "motion management" in advanced particle therapy. Several publications have reported that organ motion causes dose distribution disturbances due to interplay and blurring effects. Furthermore, motion can result in target dose miss and unwanted dose to healthy structures around the target. To avoid these problems, motion should be assessed and monitored prior and during treatment. In this review article, we give an overview about clinically available motion monitoring systems. Based on the acquired motion information an adequate motion mitigation technique should be chosen. This article reviews the clinical status of motion mitigation techniques like rescanning, gating and tracking. A limited number of centers have now started the treatment of targets in the thorax and abdomen using scanned particle beams. Therefore, the establishment of guidelines for motion monitoring and motion mitigation will be essential in the coming years.
在这篇综述文章中,我们介绍了先进粒子治疗中“运动管理”的重要性。有几项出版物报道称,由于相互作用和模糊效应,器官运动会导致剂量分布紊乱。此外,运动可能导致靶区剂量不足和靶区周围健康结构的不必要剂量。为了避免这些问题,应在治疗前和治疗过程中评估和监测运动。在这篇综述文章中,我们概述了临床可用的运动监测系统。基于所获得的运动信息,应选择适当的运动缓解技术。本文回顾了运动缓解技术(如再扫描、门控和跟踪)的临床现状。现在只有少数中心开始使用扫描粒子束治疗胸部和腹部的靶区。因此,在未来几年内,为运动监测和运动缓解制定指南将是至关重要的。